Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
about
JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinomaGenome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer.High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.A monoclonal antibody against a potential cancer biomarker, human ubiquitin-conjugating enzyme E2UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.Defining disease with laser precision: laser capture microdissection in gastroenterology.Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression.Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.Modeling and analyzing gene co-expression in hepatocellular carcinoma using actor-semiotic networks and centrality signatures.High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma.Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers.UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.Kinesin 18A expression: clinical relevance to colorectal cancer progression.The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis.Intermittent calorie restriction largely counteracts the adverse health effects of a moderate-fat diet in aging C57BL/6J mice.Regulator of G-protein signaling 5 enhances portal vein invasion in hepatocellular carcinoma.A study of UbcH10 expression and its association with recurrence of meningiomas.Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis.Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics AnalysisUBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability
P2860
Q23919676-49CB4AFA-A76B-4449-92C3-BEE328E0D4BFQ33652971-57EC9B1E-803A-48E6-87AE-8F61A51CDC8CQ34469379-3D50CC70-B88B-4730-88B0-D30CEDB06A78Q34669229-A215186B-87B4-49A6-BF83-DBD332E0066FQ34839612-D228B9F8-011B-4CFB-89AE-64AC4769F688Q36066046-DEF815DE-90A7-4D08-823B-639229CF282DQ36956211-18FF4B55-FFFD-4972-9791-247251EBB260Q37040659-22418DF1-CB86-4262-BBEC-C54CF3552836Q37076843-EAA160CD-6E3D-4772-9F5E-16CE5A989424Q37205779-ECCA89BB-F758-4D3F-BB38-6FE0CD270409Q37212003-05D6D1A6-71A4-483B-9AC4-124EC79D4BC1Q37718705-88AC1D31-F0B5-4117-8E62-3C80CDBB7311Q38514734-7C070BA3-AC64-4626-B2CC-3DC5C8210539Q38721719-C860038A-B578-4629-BEA1-F24A201BFC4AQ38891828-A48D847D-ECDA-4374-8EAD-9CA3A929C633Q38939750-8457D217-9EE3-4381-BE5C-39B7A1393DFEQ39066542-AC4D65EF-A1DB-45A9-A7A1-41E51F0DF9E5Q39320437-A7545B8D-88C7-43C5-9138-FE79022B4ED7Q39361933-BDBF7A4D-9A02-4177-9039-902CB0AEA607Q39611073-6C407390-54E6-4A14-BE4E-299DF7ECCEC5Q41365132-A147EEEF-45B6-4B8F-8097-DE5EA3E2E659Q43807519-3D084785-C5F5-4006-BE05-0F5708904D2BQ44208471-458547F9-7194-47C0-97BE-E01519B275ABQ46443002-FA1AE59C-0BD0-4DDC-B1BF-3E30427264AEQ50053727-ED659641-0B4C-4B83-9FB6-2F3404B89003Q53204970-737D0653-10C0-43F2-9E06-9593E7AFD27DQ54241791-74AE661D-E089-49DB-BB04-38FD2F552B6AQ55024946-A3200439-F248-4B25-981F-E77920D6CC6CQ58122535-8287C3C5-65C9-4ED1-B545-61718A4A9DBBQ58803439-0B64B9C3-665A-44DF-B6DA-173AE0559FBA
P2860
Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Identification of overexpresse ...... ng enzyme E2C gene expression.
@ast
Identification of overexpresse ...... ng enzyme E2C gene expression.
@en
type
label
Identification of overexpresse ...... ng enzyme E2C gene expression.
@ast
Identification of overexpresse ...... ng enzyme E2C gene expression.
@en
prefLabel
Identification of overexpresse ...... ng enzyme E2C gene expression.
@ast
Identification of overexpresse ...... ng enzyme E2C gene expression.
@en
P2093
P2860
P356
P1476
Identification of overexpresse ...... ng enzyme E2C gene expression.
@en
P2093
Eiki Ojima
Fumiaki Tanaka
Hiroshi Inoue
Hiroyuki Kuwano
Keisuke Ieta
Koshi Mimori
Masaki Mori
Naotsugu Haraguchi
Yoshito Nakamura
P2860
P356
10.1002/IJC.22605
P577
2007-07-01T00:00:00Z